Friday, June 29, 2012

Reuters: Global Markets: Ampio shares rise on bullish online report

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Ampio shares rise on bullish online report
Jun 29th 2012, 16:47

Fri Jun 29, 2012 12:47pm EDT

(Reuters) - Shares of Ampio Pharmaceuticals Inc rose as much as 39 percent on Friday after an investment website said it expects Ampio to be the next "blockbuster" stock.

With 3 blockbuster drugs, Ampio is all primed up for loads of news about clinical trials, the FDA and potential partners, Seeking Alpha said in a report published on Friday.

Ampio's drug to treat premature ejaculation is in a late-stage study, while its diabetes related eye disease and anti-inflammation drugs have completed mid-stage trials.

The website said Ampio's stock could follow hot stocks such as Arena Pharmaceuticals, Vertex Pharmaceuticals and Onyx Pharmaceuticals.

The company's shares were up 32 percent at $5.20, making them one of the top percentage gainers on Friday on the Nasdaq. They touched a high of $5.49 earlier in the day.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Alamos shares rise on positive results for Turkey mines

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Alamos shares rise on positive results for Turkey mines
Jun 29th 2012, 16:01

Fri Jun 29, 2012 12:01pm EDT

(Reuters) - Shares of Alamos Gold Inc (AGI.TO) rose as much as 9.3 percent after the miner reported positive results from a pre-feasibility study conducted at its gold projects in Turkey.

The company said it expects average annual gold production of 166,000 ounces over the nine year combined life of the Agi Dagi and Kirazli gold mines located in northwestern Turkey.

The mines hold a total of 1.5 million ounces of gold and 4.9 million ounces of silver, Alamos said in a statement on Thursday.

Analysts were, however, cautious, flagging concerns over likely delays to start of production.

Macquarie analysts reduced their price target on Alamos's stock to C$19 from C$20, citing concerns over environmental permits that may delay start of commercial production.

"Final environmental impact studies approval timelines for Kirazli and Agi Dagi have been pushed back six months to first and second quarter of 2013, respectively," the brokerage said in a note to clients.

Macquarie said it expects commercial production to start in early 2015, "but see the potential for further delays to emerge," and maintained its "outperform" rating on the stock.

Alamos sees first gold production from the Kirazli project in 2014 and from Agi Dagi in 2016.

Dundee Capital Markets and Desjardins also cut their price targets on likely delays due to revisions in the environmental impact assessment but maintained a "buy" rating.

Dundee cut its price target on the company's stock to C$24 from C$25 and Desjardins lowered it to C$21.25 from C$24.50.

Frazer Mackenzie raised it price target on the stock to $25.00 from $24.75 as it expects higher gold production and maintained its "strong buy" rating.

Shares of Toronto, Ontario-based Alamos were up 8 percent at C$15.66 on Friday on the Toronto Stock Exchange. They touched a high of C$15.87 earlier.

(Reporting by Maneesha Tiwari in Bangalore; Editing by Sriraj Kalluvila)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: AZZ shares hit life-high as co raises forecast

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
AZZ shares hit life-high as co raises forecast
Jun 29th 2012, 15:10

Fri Jun 29, 2012 11:10am EDT

(Reuters) - Shares of AZZ Inc (AZZ.N) rose 17 percent to a life high after the electrical equipment maker posted better-than-expected quarterly results and raised its outlook for fiscal 2013.

The company raised its full-year profit outlook to $4.10 to $4.30 per share, from $3.25 to $3.55 per share.

The electrical equipment maker now expects revenue of $550 million to $575 million, up from its previous forecast of $475 million to $510 million.

First-quarter revenue at the company's galvanizing service segment rose 25 percent to $82.5 million, while revenue at its electrical and industrial products segment fell 7 percent to $44.7 million.

The company also announced a 2 for 1 stock split payable in July.

Shares of Fort Worth, Texas-based AZZ were up 14 percent at $58.31 on Friday morning, making them one of the top percentage gainers on the New York Stock Exchange.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Tibco shares rise on strong results

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Tibco shares rise on strong results
Jun 29th 2012, 14:03

Fri Jun 29, 2012 10:03am EDT

(Reuters) - Shares of Tibco Software Inc (TIBX.O) rose as much as 11 percent on Friday after the software maker reported second-quarter results above analysts' expectations, helped by higher revenue from new licenses.

Tibco on Thursday said revenue rose 14 percent to $247.4 million. Revenue from licenses grew 13 percent to $92.6 million.

The company's verticals outside of financial services and telecom grew 20 percent year over year, showing improved vertical diversification, and strong performance came from the healthcare, life sciences and retail segments, analysts at Susquehanna said in note to clients.

Tibco also removed its U.S. head of sales, Robin Gilthorpe, as the company's growth in its biggest market, the Americas, lagged Europe and Asia.

"Americas execution seemed to be a disappointment, and Tibco fired its head of Americas sales and plans to make minor tweaks to its sales focus," the brokerage said.

Tibco shares touched more than a month's high of $29.86 in early trading on the Nasdaq.

(Reporting by Supantha Mukherjee in Bangalore; Editing by Maju Samuel)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: ServiceNow opens 32 percent above IPO price on NYSE

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
ServiceNow opens 32 percent above IPO price on NYSE
Jun 29th 2012, 14:13

Fri Jun 29, 2012 10:13am EDT

(Reuters) - ServiceNow Inc (NOW.N) soared 29 percent in its New York Stock Exchange stock debut on Friday, as the information technology software company reawakened a market that had cooled in the aftermath of Facebook Inc's (FB.O) initial public offering.

Shares of the San Diego, California-based company opened at $23.28, up $5.28, after pricing at $18, above the expected range. ServiceNow sold 11.65 million shares, raising $209.7 million.

ServiceNow had intended to price shares in a range of $15 to $17. The company sold 9 million shares, while company founder Fred Luddy sold the remaining 2.65 million shares.

In fiscal year 2011, ServiceNow revenue more than doubled to $92.6 million, and it posted a profit of $9.8 million after a loss of $29.7 million in 2010.

ServiceNow's IPO is being underwritten by Morgan Stanley, Citigroup Inc, Deutsche Bank AG, Barclays, Credit Suisse, UBS AG, Pacific Crest Securities and Wells Fargo & Co.

ServiceNow will use the proceeds for working capital and other general corporate purposes.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Peabody leases coal reserves, stock up

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Peabody leases coal reserves, stock up
Jun 29th 2012, 12:55

Fri Jun 29, 2012 8:55am EDT

(Reuters) - Coal miner Peabody Energy Corp (BTU.N) said on Friday it has leased 721 million tons of ultra-low-sulfur coal reserves adjacent to its North Antelope Rochelle Mine in the Powder River Basin of Wyoming.

The company's shares rose over 3 percent to $24.07 in pre-market trading on the New York Stock Exchange.

Peabody said it submitted a bid of $1.10 per mineable ton for control of the North Porcupine reserve area to the U.S. Bureau of Land Management, which awarded the lease following a sealed-bid auction.

Peabody has leased more than 1.1 billion tons of reserves adjacent to North Antelope Rochelle in recent months, and the company controls 4 billion tons of coal reserves in the region.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: KB Home second-quarter loss narrows as orders rise

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
KB Home second-quarter loss narrows as orders rise
Jun 29th 2012, 12:33

Newly finished development of homes for sale, built by home builder KB Homes, are pictured in Carlsbad, California January 4, 2011.

Credit: Reuters/Mike Blake

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Grupo Modelo shares rise on AB InBev purchase report

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Grupo Modelo shares rise on AB InBev purchase report
Jun 29th 2012, 11:59

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: RIM on the edge after grim results, launch delay

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
RIM on the edge after grim results, launch delay
Jun 29th 2012, 11:18

A logo of the Blackberry maker's Research in Motion is seen on a building at the RIM Technology Park in Waterloo April 18, 2012. REUTERS/Mark Blinch

A logo of the Blackberry maker's Research in Motion is seen on a building at the RIM Technology Park in Waterloo April 18, 2012.

Credit: Reuters/Mark Blinch

Fri Jun 29, 2012 7:18am EDT

(Reuters) - Research In Motion Ltd could run out of cash and ultimately fail, even with the launch of its now-delayed BlackBerry 10 device early next year, Wall Street analysts said.

At least 10 brokerages cut their price targets on the stock, some by as much as 50 percent, a day after the company reported worse-than expected quarterly results and said it would delay the launch of its next-generation device to early 2013 from late this year.

RIM shares were down 15 percent in pre-market trading on the Nasdaq.

"If RIM continues to be run as it is, we believe that the company will eventually fail," Nomura Equity Research said.

"We do not expect RIM to successfully drive a turnaround of its financials, even with the launch of BB10 next year," the brokerage said in a note to clients, adding that its model assumes that RIM disappears by 2020 in a gradual decline.

BlackBerry 10, considered to be RIM's make-or-break product, was originally slated to be launched in the first quarter and the delay has already contributed to a 40 percent drop in the company's stock price so far this year.

"Given RIM's cash burn, BB10 can't come soon enough," Barclays said in a note to clients.

Analysts at Citi Investment Research and Jefferies slashed their price targets on the stock to $5.00 for RIM's U.S.-listed shares, a fall of 45 percent from Thursday's close.

"We believe fundamentals continue to get worse and RIMM could run out of cash and need to raise capital within two years implying that as time rolls forward, if we are correct, the value of RIMM continues to go lower," the Citi analysts said.

"We expect more write-offs and impairments to RIMM assets and we question if RIMM's new BB10 products will even matter as it may be too little too late," the analysts said.

RIM said it would lay off 5,000 workers, about 30 percent of its workforce, as it tries to save cash, although some analysts noted that this would come at a short-term cost.

Citi said the layoffs it believed the company should be hiring instead of firing to get products out on time. "With the distraction of this large layoff, it will be difficult to retain and motivate employees to develop new products."

With a weak product portfolio and the BlackBerry 10 delay, RIM faces continued volume pressure as well declining average selling prices, said Credit Suisse, which cut its price target on the company's U.S.-listed shares to $7 from $11.

"While the stock remains cheap, only the potential for an outright sale of the company or a break-up keeps us at a "neutral" (rating)," the brokerage said.

RIM's board is under increasing pressure to consider unpalatable options such as selling its network business or forming an alliance with Microsoft Corp, three sources familiar with the situation said on Thursday.

CIBC cut its rating on RIM to "sector underperformer" from "sector outperformer." National Bank Financial, however, raised its rating to "sector perform" from "underperform", saying it was time to get off short positions.

Shares of RIM, which have dropped about 70 percent over the past year, were down 15 percent at $7.75 in pre-market trading. The stock closed at $9.46 in Toronto on Thursday.

(Reporting by Sagarika Jaisinghani in Bangalore; Editing by Tenzin Pema and Ted Kerr)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Thursday, June 28, 2012

Reuters: Global Markets: OGX CEO Mendonca steps down after shares plummet

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
OGX CEO Mendonca steps down after shares plummet
Jun 29th 2012, 02:02

RIO DE JANEIRO | Thu Jun 28, 2012 10:02pm EDT

RIO DE JANEIRO (Reuters) - OGX Petroleo de Gas (OGXP3.SA), Brazil's second-largest oil company by market value, said on Thursday that chief executive Paulo Mendonca has resigned but will remain an advisor to the company's controlling shareholder.

Mendonca's departure comes after the company's shares have fallen 51 percent so far in June and 45 percent in the last two days on concern that the company's output targets will not be met.

This month's declines have wiped 17 billion reais ($8.2) billion) off the company's market value and hit Brazilian billionaire Eike Batista, the company's controlling shareholder and Brazil's richest man, with a more than 10 billion-real loss on his shares.

Mendonca will be replaced by Luiz Eduardo Carneiro, chief executive of shipbuilder and leaser OSX Brasil (OSXB3.SA), OGX said in a Brazilian securities filing.

Analysts downgraded the company in recent weeks after the company cut its daily production estimates for its Tubarao Azul field, an offshore area northeast of Rio de Janeiro.

Mendonca and OGX said that the flow levels were being improperly interpreted and that they stood by their estimate that Tubarao Azul, or "Blue Shark," will produce the expected 110 million barrels of oil over the next three decades.

That amount is enough to supply the needs of the United States, the world's largest oil consumer, for about six days, according to BP Plc (BP.L) and Reuters data.

Despite the explanations and a conference call with investors on Wednesday, OGX shares fell 25.3 percent Wednesday and 19.2 percent Thursday in Sao Paulo trading. At 5.05 reais a share, the stock now trades at its lowest level in more than three years.

OGX, founded in 2007, produced its first oil at Tubarao Azul in January after an exploration and development campaign that was one of the fastest on record. OGX says it plans to produce about 1.4 million barrels of oil and natural gas by the end of 2019.

If OGX succeeds, it will likely help Brazil overtake the United States as the world's No.3 oil producer after Russia and Saudi Arabia.

(Reporting by Jeb Blount, Fabio Couto and Juliana Schincariol; Editing by Matt Driskill)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Vertex shares fall as investors doubt drug data

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Vertex shares fall as investors doubt drug data
Jun 28th 2012, 21:09

By Toni Clarke and Bill Berkrot

Thu Jun 28, 2012 5:09pm EDT

(Reuters) - Vertex Pharmaceuticals Inc (VRTX.O) said its combination cystic fibrosis treatment significantly improved patient lung function in a mid-stage clinical study, but investor skepticism about how the results were presented and over the strength of the data itself sparked a sharp selloff of company shares.

Vertex shares closed down 16.2 percent at $51.18 on Thursday and were off as much as 21.7 percent at the depth of the selloff.

The data was the final results from a Phase II study of Vertex's cystic fibrosis drug Kalydeco in combination with an experimental drug, VX-809. Interim results from the trial presented last month sent the company's shares soaring as they appeared to show a surprisingly strong improvement in lung function in patients with the life-shortening disease.

Some of those gains were later lost after the company was forced to revise the data due to a statistical mistake in which it confused relative with absolute results. The final results presented on Thursday contained ambiguities that further unsettled investors.

"This is now the third and most confusing disclosure about a relatively small study, and this one raises even more questions about management's transparency and credibility," said Sanford Bernstein analyst Geoffrey Porges, who has been a strong supporter of Vertex in the past.

In particular, the company did not present exactly comparable results between the interim and final data.

"This non apples-to-apples disclosure has created investor doubt that the data are 'real,'" said Mark Schoenebaum, an analyst at ISI Group, in a research note.

Company executives told analysts on a conference call that even though it did not present exactly comparable results, the final results should stand alone and indicate the treatment is effective at the highest VX-809 dose of three tested. Vertex said the results warrant moving forward into late-stage clinical development, which it plans to begin in early 2013.

"At the interim analysis they encouraged everybody to focus on the difference between day zero - the start of treatment - and day 56 - the end of treatment - which is a logical approach. But in final analysis they asked everyone to focus on halfway through the study at day 28 and day 56," Porges said.

"They (Vertex management) believed that they could move the goal posts on the disclosure, spin the story heavily in their favor and not see a reaction. I don't think that they'll believe that after today."

The company declined to comment on the steep drop in its share price.

Kalydeco, which in January became the first drug approved to treat the underlying cause rather than symptoms of the serious lung disease, helps about 4 percent of cystic fibrosis patients with a specific gene mutation.

Vertex is hoping that the drug, when combined with VX-809, will eventually be able to treat the larger cystic fibrosis population.

Cystic fibrosis causes the thin layer of mucus that helps keep lungs free of germs to thicken, clogging airways and damaging the lungs. The average life expectancy for the disease is 37 years as damage to the lungs progresses, limiting the ability to breath.

(Reporting by Toni Clarke in Boston and Bill Berkrot and Lewis Krauskopf in New York; editing by Jeffrey Benkoe and Matthew Lewis)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Nike profit shy of estimates, shares fall

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Nike profit shy of estimates, shares fall
Jun 28th 2012, 21:32

Nike running shoes are seen in Los Angeles, California March 20, 2012. Nike, Inc. plans to release its third quarter fiscal 2012 financial results on March 22.

Credit: Reuters/Lucy Nicholson

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Grupo Modelo shares rise on AB InBev purchase report

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Grupo Modelo shares rise on AB InBev purchase report
Jun 28th 2012, 19:18

MEXICO CITY | Thu Jun 28, 2012 3:18pm EDT

MEXICO CITY (Reuters) - Shares in Mexican brewer Grupo Modelo (GMODELOC.MX) shot up on reports that beer giant Anheuser-Busch InBev could announce a deal as soon as Friday to buy out the company.

Shares rose as much as 5.1 percent after Reuters reported Belgian-based Anheuser-Busch InBev (ABI.BR) was in advanced talks with family shareholders who control Modelo.

Modelo was trading up 3.57 percent at 117.390 pesos per share in afternoon trading.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Highfields ups Genworth stake, to discuss options for MI unit

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Highfields ups Genworth stake, to discuss options for MI unit
Jun 28th 2012, 18:35

By Jochelle Mendonca and Sharanya Hrishikesh

Thu Jun 28, 2012 2:35pm EDT

(Reuters) - Hedge fund Highfields Capital raised its stake in Genworth Financial Inc (GNW.N) and said it expects to discuss options for the insurer's U.S. mortgage insurance operations and other businesses.

Genworth's shares rose 9 percent to $5.37 in afternoon trade on the New York Stock Exchange.

The discussions would include a possible sale or spinoff of assets, the hedge fund said in a filing with the U.S. Securities and Exchange Commission.

Highfields, which had reported a 3.8 percent stake as of March 31, now owns 5.2 percent of the insurer.

Genworth's U.S. mortgage insurance unit has been losing money as it continues to deal with souring mortgages insured at the height of the housing boom.

Long-time Genworth Chief Executive Michael Frazier resigned in May after the insurer pushed back plans to sell a minority stake in its Australian mortgage insurance business through an initial public offering.

The Australian unit's listing would have freed up capital, which shareholders were hoping would be used for a long-awaited share buyback program.

"I think it has been the view of many investors that Michael Frazier as CEO was an impediment to change. Now given that the board is going through its own strategic review, it may be more receptive to Highfields' ideas," BTIG analyst Mark Palmer said.

Investors have often been critical of Genworth for not doing enough to boost its share value, with hedge fund maven Steve Eisman even threatening a proxy war.

Bond rating agency Moody's on Wednesday said it was placing the company on credit review for a possible downgrade to junk with about $4.3 billion of debt affected.

The rating agency said that Genworth's debt rating, currently at the lowest investment-grade level on its scale, could be downgraded based on a failure to delink the U.S. MI unit from the holding company's creditors.

While Genworth's life insurance operations have a strong credit rating, the holding company is being hurt by the poor outlook for the mortgage insurance business.

(Editing by Saumyadeb Chakrabarty, Supriya Kurane)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Jakks slumps in post-buyback selloff

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Jakks slumps in post-buyback selloff
Jun 28th 2012, 16:44

Thu Jun 28, 2012 12:44pm EDT

(Reuters) - Shares of Jakks Pacific Inc (JAKK.O) tumbled 16 percent on Thursday after the toymaker said it would accept 15.8 percent of the stock tendered by each shareholder in its $80 million share buyback, disappointing investors who had hoped for more.

The company said 22.7 million shares were tendered by the expiry of the offer on Wednesday, representing almost all of the shares outstanding.

Oaktree Capital Management (OAK.N), which holds about 5 percent of Jakks, has been trying to buy the company for $670 million. Jakks had offered $20 per share, matching Oaktree's offer.

Oaktree was not immediately available to comment.

The 4 million shares Jakks accepted for purchase represent 15.4 percent of the shares outstanding.

"People are disappointed and selling the shares they won't get tendered," Edward Woo of Ascendiant Capital Markets said.

Oaktree ended talks over a standstill pact with the company after the two parties failed to agree on terms. A standstill pact would have capped Oaktree's stake in Jakks.

Jakks shares were down 9 percent at $16.30 in early afternoon trade. They touched a low of $15.10 earlier on Thursday.

(Reporting by Juhi Arora in Bangalore, Ted Kerr, Viraj Nair)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Encana shares jump on Petronas bid for rival

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Encana shares jump on Petronas bid for rival
Jun 28th 2012, 16:25

CALGARY, Alberta | Thu Jun 28, 2012 12:25pm EDT

CALGARY, Alberta (Reuters) - Shares of Encana Corp (ECA.TO), Canada's largest natural gas producer, rose as much as 7.8 percent on Thursday after Malaysia's state oil company said it will buy Encana rival Progress Energy Resources Corp (PRQ.TO) for a rich premium.

Shares of Encana were up C$1.5, or 5.3 percent, at C$20.80 by late morning on the Toronto Stock Exchange after touching as high as C$21.29. Earlier in the week the stock had been battered by a Reuters report that Encana had worked with Chesapeake Energy Corp (CHK.N) to lower land prices at a promising Michigan oil and gas field, and by an ill-received decision to boost capital spending.

Thursday's jump came after Malaysia's Petroliam Nasional Bhd PETR.UL, better known as Petronas, said it will buy Progress Energy for C$4.8 billion ($4.6 billion), offering C$20.45 for each share of the Calgary-based gas producer, a 77 percent premium to Progress's Wednesday close.

The rich offer was made to gain control of Progress's shale and unconventional gas fields in Western Canada, including those that Petronas bought a stake in last year.

The bid caused investors to rethink the values given to Encana and other Canadian companies that control vast shale gas fields in northeastern British Columbia and Alberta containing trillions of cubic feet of natural gas.

The offer "is multiples above where most of the gas names were trading," said Michael Dunn, an analyst at FirstEnergy Capital. "A 77 percent premium is such an outlier to where these stocks are being valued."

Other gas producers on the Toronto Stock Exchange had sharp gains on Wednesday: Arc Resources Ltd (ARX.TO) was up C$1.35, or 6.6 percent, at C$21.77, while Bonavista Energy Corp (BNP.TO) rose 75 Canadian cents, or 5.1 percent, to C$15.49, and Advantage Oil & Gas Ltd (AAV.TO) climbed 18 Canadian cents, or 6.4 percent, to C$2.99.

($1=$1.03 Canadian)

(Reporting by Scott Haggett; Editing by Peter Galloway)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Linde shares dip on U.S. acquisition reports

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Linde shares dip on U.S. acquisition reports
Jun 28th 2012, 16:29

FRANKFURT | Thu Jun 28, 2012 12:29pm EDT

FRANKFURT (Reuters) - Shares in German group Linde (LING.DE), the world's No. 2 industrial gases producer, fell on Thursday on the back of reports it was bidding for U.S. respiratory healthcare provider Lincare (LNCR.O) with an offer that could reach $3.4 billion.

Linde shares closed down 1.6 percent at 117.20 euros.

Lincare shares rose a quarter in value on Wednesday after the Financial Times Alphaville blog reported that French group Air Liquide (AIRP.PA) - the top industrial gas supplier, and an unnamed private equity bidder may also be in the running for Lincare, as well as Linde.

The blog named Rothschild and Lazard as advisers working on the deal and the price Linde might have to pay could be at $40 per share or more. Lincare shares were up 0.5 percent at $31.33 at 1600 GMT.

Air Liquide, whose shares closed down 0.1 percent, and Linde declined comment to Reuters.

Lincare is a provider of oxygen and respiratory therapy services to patients in the home, with customers suffering from ailments such as emphysema, chronic bronchitis or asthma.

DZ Bank analyst Peter Spengler said any acquisition by Linde of a U.S. company providing such services would fit its strategy to expand into the high-growth homecare sector.

"Linde's strategy is to sell their gases, which they produce at a very low price, at a very high premium," Spengler said, adding an acquisition price of $40 per share would be dilutive of Linde's future earnings.

"It might be financed by additional debt and free cash flow. However a capital hike cannot be ruled out," Spengler said. As of end-2011, Linde's debt stood at 5.09 billion euros ($6.3 billion).

Commerzbank said Linde could finance such a takeover without a capital increase.

Linde chief executive Wolfgang Reitzle told reporters last month the company might make further acquisitions in the healthcare business, and any possible deal would be manageable in size.

Linde bought Air Products' European homecare business in January for $750 million. The business mostly supplies oxygen and other treatments to patients in their homes. That acquisition made Linde a strong No.2 in the homecare business after Air Liquide.

DEFENSIVE STOCK

While industrial gas companies have generally been regarded as defensive stocks, shrinking demand in southern Europe, which has been hit by Europe's debt crisis, and weakness in the electronics industry have slowed profit growth.

Industrial gas suppliers have recently made inroads into the homecare market, which is growing 6-9 percent annually, driven mainly by cost-cuts in hospital operators and an aging population.

"Treating a patient with lung disease at home is far cheaper than in a hospital. We thus believe annual growth of this market to be above the 6 percent of the general healthcare gases market," Commerzbank said in its note.

While Lincare's operating margins are relatively high, some analysts said its free cash flow had been negative in the past few quarters due to a reimbursement backlog at U.S. hospitals.

According to ThomsonReuters' StarMine data, Lincare trades at 13.4 times estimated 12-months earnings, a premium to U.S. rivals Baxter International's (BAX.N) 11.3 multiple, HCA's (HCA.N) 7.1, and an industry average of 8.5.

Lincare has a market capitalization of $2.69 billion while Linde's is $25.5 billion.

($1 = 0.8028 euro)

(Reporting By Marilyn Gerlach)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Curtiss-Wright cuts earnings outlook on charges

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Curtiss-Wright cuts earnings outlook on charges
Jun 28th 2012, 14:22

Thu Jun 28, 2012 10:22am EDT

(Reuters) - Curtiss-Wright Corp (CW.N) cut its second-quarter and full-year earnings outlook, citing costs related to the restructuring of a segment and unanticipated investments in China, sending its shares sliding 7 percent before the bell.

The aerospace and defense component maker said it will take second-quarter non-cash charges of about 8 cents per share related to the restructuring of its metal treatment segment.

The company also expects unanticipated investments in a China program to hurt earnings by 8 cents per share in the quarter.

Higher labor costs for painting, disassembly, inspection and packaging have pushed up investments in China.

The Parsippany, New Jersey-based company now expects second-quarter earnings of 44 cents to 48 cents per share, down from its prior outlook of 60 cents to 64 cents.

Curtiss-Wright cut its full-year earnings outlook to $2.50 to $2.60 per share, from $2.58 to $2.68 per share.

Curtiss-Wright shares were down 7 percent in trading before the bell. They closed at $30.66 on Wednesday on the New York Stock Exchange.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Global Markets: Hospital stocks jump after U.S. health law ruling

Reuters: Global Markets
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Hospital stocks jump after U.S. health law ruling
Jun 28th 2012, 14:53

Thu Jun 28, 2012 10:53am EDT

(Reuters) - Shares of hospital chains jumped on Thursday after the U.S. Supreme Court upheld the centerpiece of U.S. President Barack Obama's signature healthcare law.

Hospital company Community Health Systems Inc jumped 8 percent, while Tenet Healthcare Corp rose almost 5 percent.

Shares of health insurers were mixed. Large diversified companies such as Aetna Inc and WellPoint were off 4 percent and 6 percent respectively.

But insurers that specialize in Medicaid jumped, with Amerigroup Corp climbing 4.6 percent, and Molina Healthcare Inc up 7.6 percent.

A sharply divided U.S. Supreme Court upheld the centerpiece of Obama's signature healthcare overhaul law that requires that most Americans get insurance by 2014 or pay a financial penalty.

The 2010 law is designed to expand coverage to more than 30 million currently uninsured Americans, through insurance exchanges where people can shop for coverage and an expansion of the Medicaid program for low-income Americans.

Expanding the pool of paying patients stands to benefit hospital companies since they will have more paying customers with insurance instead of uninsured patients.

"The status quo was maintained," said Tim Nelson, an analyst with Nuveen Asset Management. "There was fear that if the mandate went away, hospitals would lose volume. Hospitals should be a major beneficiary of this whole thing, but the uncertainty isn't going away. Now it'll just shift to the election."

Under the law, insurers face government review of premium rate increases, requirements of spending on medical care and fees on the sector starting in 2014.

Shares of five different healthcare companies were temporarily halted, some more than once, after the ruling was announced due to sharp moves.

(Reporting by Lewis Krauskopf; additional reporting by Chuck Mikolajczak in New York and Debra Sherman in Chicago; editing by Gerald E. McCormick and Jeffrey Benkoe)

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

 
Great HTML Templates from easytemplates.com.